Review Article
Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review
Table 7
Symptoms and consequences of Parkinson’s patients with COVID-19.
| Worsened symptoms | References | Total | [10] | [11] | [12] | [13] | [40] | [15] | [16] | [17] | [18] | [19] | [20] | [37] | [38] |
| 1. Abnormalities of movement (motor functioning) | | + | | + | | | | | + | | | | + | 4 | 1.1. Tremor/shaking | | | | + | | | | | | | | | | 1 | 1.2. Walking troubles | | | | + | | | | | | | | | | 1 | 1.3. Gait and balance disturbances | | | | + | | | | | | | | | | 1 | 1.4. Bradykinesia | | | | + | | | | | | | | | | 1 | 1.5. Dyskinesia | | | | + | | | | | | | | | | 1 | 1.6. Rigidity (frigidity) | | | | + | | | | | | | | | | 1 | 1.7. Falling | | | | + | | | | | | | | | | 1 | 1.8. Disability | | | | | | | | | + | | | | | 1 | 1.9. Dystonia | | | | + | | | | | | | | | | 1 | 1.10. Freezing | | | | + | | | | | | | | | | 1 | 2. Nonmotor functioning (psychiatric symptomatology) | | | | + | | | | | + | | | | + | 3 | 2.1. Sensations (such as aches, cramps, and tingling) | | | | + | | | | | | | | | | 1 | 2.2. Thought disorders | | | | + | | | | | | | | | | 1 | 2.3. Distress/depression | | | | + | | | | | | | | | | 1 | 2.4. Anxiety and stress | | | | + | | | | | | | | | | 1 | 2.5. Cognitive dysfunction | | | | | | | | | + | | | | + | 2 | 2.6. Sleep disorders (insomnia) | | | | + | | | | | + | | | | | 2 | 2.7. Speech disorders (stuttering) | | | | + | | | | | | | | | | 1 | 2.8. Mentation | | | | + | | | | | | | | | | 1 | 2.9. Mood disturbances (anger, irritability, and frustration) | | + | | | | | | | + | | | | + | 3 | 2.10. Dementia | | | | | + | | | + | | | | | | 2 | 3. Clinical outcomes (pain and cough) | | | | | | | | | | | | | | — | 3.1. Pain | + | | + | + | | | | | + | | | | | 4 | 3.2. Anorexia | | | | | | + | | | + | | | | | 2 | 3.3. Fatigue | | | | | | | | | + | | | | | 1 | 3.4. Weakness | | + | | | | | | | | | | | | 1 | 3.5. Fever | + | | + | | | | | | + | | | | | 3 | 3.6. Hypertension | | | | | | | | | | | + | + | | 2 | 3.7. Cough | + | | | | | + | | | + | | | | | 3 | 3.8. Dyspnea | + | | | | | | | | + | | | | | 2 | 3.9. Headache | + | | | | | | | | | | | | | 1 | 3.10. Constipation | | | | + | | | | | | | | | | 1 | 3.11. Diarrhea | | | | | | | | | + | | | | | 1 | 3.12. Smell loss | | | | | | | | | + | | | | + | 2 | 3.13. Vitamin D deficiency | | | | | | | | | | | + | | | 1 | 3.14. Urinary disorders | | | | + | | | | | + | | | | | 2 | 3.15. Cardiac disease | | | | | | | | | | | + | | | 1 | 3.16. Cerebrovascular disease | | | | | | | | | | | + | | | 1 | 3.17. Diabetes | | | | | | | | | | | + | + | | 2 | 3.18. Kidney disease | | | | | | | | | | | + | | | 1 | 3.19. Flu | | | | | | | | | | | | + | | 1 | 3.20. Lung disease | | | | | | | | | | | | | + | 1 | 4. Activities of daily living | | | | | | | | | | | | | | — | 4.1. Salivation | | | | + | | | | | | | | | | 1 | 4.2. Hand writing | | | | + | | | | | | | | | | 1 | 4.3. Dressing | | | | + | | | | | | | | | | 1 | 4.4. Turning in bed | | | | + | | | | | | | | | | 1 | 4.5. Swallowing | | | | + | | | | | | | | | | 1 | 4.6. Cutting food | | | | + | | | | | | | | | | 1 | 4.7. Hygiene | | | | + | | | | | | | | | | 1 | 4.8. Autonomic | | | | | | | | | | | | | + | 1 | 5. Other outcomes | | | | | | | | | | | | | | — | 5.1. Hospitalization | | + | | | | | | | | | | | | 1 | 5.2. Mortality rate | | + | | | | | + | | | | + | + | | 4 | 5.3. Prevalence | | | | | | | | | | | | + | | 1 | 5.4. Case fatality | | | | | | | | | | | | + | | 1 | PD is risk factor (yes or no) | No | Yes | No | No | No | Yes | No | No | Yes | Yes | Yes | Unclear | Yes | Yes: 6 No: 6 Unclear: 1 |
|
|